Serum 7S domain of type iv collagen levels in essential hypertension and hypertensive type 2 diabetic patients

Diabetic Medicine

Volumn 14, Issue 6, 1997, Pages 466-471

  Yano, Y ^a   Ura, H ^a   Sumida, Y ^a   Gabazza, E C ^a   Misaki, M ^b   Shima, T ^a  

^a MIE UNIVERSITY   (Japan)

^b National Hisai Hospital   (Japan)

Author keywords

Basement membrane; Diabetes mellitus; Hypertension; Type IV collage; Vascular complication

Indexed keywords

COLLAGEN TYPE 4; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD LEVEL; COLLAGEN METABOLISM; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGE FACTORS; ALBUMINURIA; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; COLLAGEN; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DIASTOLE; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INSULIN; MALE; MIDDLE AGED; PROTEIN STRUCTURE, TERTIARY; SYSTOLE;

EID: 0030790215     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199706)14:6<466::AID-DIA383>3.0.CO;2-U     Document Type: Article

References (39)

1. Hernandez AM, Amenta PS. Basement membrane in pathology. Lab Invest 1983; 48: 656-677.
2. Risteli J, Bachinger HP, Engle J, Furthmayr H, Timple R. 7-S collagen: characterization of an unusual basement membrane structure. Eur J Biochem 1980; 108: 239-250.
3. Falk RJ, Scheinman JI, Mauer SM, Micheal AF. Polyantigenic expansion of basement membrane constitutes in diabetic nephropathy. Diabetes 1983; 32 (suppl 2): 34-39.
4. Karttunen T, Risteli J, Harmainen HA, Risteli L. Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. Kidney Int 1986; 30: 586-591.
5. Roy S, Maiello M, Lorenzi M. Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest 1994; 93: 438-442.
6. Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 1991; 40: 102-110.
7. Akisaka M, Spiro MJ, Spiro RG. Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen. Diabetes 1994; 43: 95-103.
8. Högemann B, Voss B, Altenwerth FJ, Schneider M, Rauterberg J, Gerlach U. Concentration of 7S collagen and laminin P1 in sera of patients with diabetes mellitus. Klin Wochenschr 1986; 664: 382-385.
9. Matsumoto E, Matsumoto C, Ooshima A, Kikuoka H, Bessho H, Miyamura K, et al. Serum type IV collagen concentrations in diabetic patients with microangiopathy as determined by enzyme immunoassay with monoclonal antibodies. Diabetes 1990; 39: 885-890.
10. Gall MA, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-661.
11. Schmitz A, Væth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 1994; 37: 1251-1258.
12. Cignarelli M, Decicco ML, Damato A, Paternostro A, Pagliarini S, Santro S, et al. High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients. Diabetes Care 1992; 15: 1002-1008.
13. Nelson RG, Wolfa JA, Horton MB, Pettitt DJ, Bennett PH, Knowler WC. Proliferative retinopathy in NIDDM, incidence and risk factors in Pima Indians. Diabetes 1989; 38: 435-440.
14. Dupree EA, Meyer MB. Role of risk factors in the complications of diabetes mellitus. Am J Epidemiol 1980; 112: 109-112.
15. Bell DSH. Stroke in the diabetic patients. Diabetes Care 1994; 17: 213-219.
16. Roggendorf W, Opitz H, Schuppan D. Altered expression of collagen type VI in brain vessels of patients with chronic hypertension. A comparison with the distribution of collagen type IV and procollagen III. Acta Neuropathol 1988; 77: 55-60.
17. Lipke DW, McCarthy KJ, Elton TS, Arcot SS, Oparil S, Couchman JR. Coarctation induces alterations in basement membrane in the cardiovascular system. Hypertension 1993; 22: 743-753.
18. WHO Expert Committee on Diabetes Mellitus. Diabetes Mellitus: Second Report. Technical Report Series 646. Geneva: WHO, 1980.
19. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89-93.
20. Guidelines Sub-Committee. 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertension 1993; 11: 905-918.
21. Misaki M, Shima T, Yano Y, Sumida Y, Kano U, Murata T, et al. Basement membrane related and type III procollagen-related antigens in serum of patients with chronic viral liver disease. Clin Chem 1990; 36: 522-524.
22. Rasamussen LM, Ledet T. Aortic collagen alterations in human diabetes mellitus. Changes in basement membrane collagen content and in the susceptibility of total collagen to cyanogen bromide solubilisation. Diabetologia 1993; 36: 445-453.
23. Mattock MB, Keen H, Viberti GC, El-Gohari MR, Murrells TJ, Scott GS, et al. Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988; 31: 82-87.
24. Danne T, Spiro MJ, Spiro RG. Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial and mesangial cells. Diabetes 1993; 42: 170-177.
25. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glyosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 1992; 89: 2873-2877.
26. Tarsio JF, Reger LA, Furcht LT. Decreased interaction of fibronectin, type IV collagen and heparin due to nonenzymatic glycation. Implications for diabetes mellitus. Biochemistry 1987; 26: 1014-1020.
27. Ledbetter S, Copeland EJ, Noonan D, Vogeli G, Hassell JR. Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 1990; 39: 196-203.
28. Risteli J, Draeger KE, Regitz G, Neubauer HP. Increase in circulating basement membrane antigens non diabetic rats and effects of insulin treatment. Diabetologia 1982; 23: 266-269.
29. Inomata S, Itoh M, Sato T. Difference of serum levels of Type IV collagen 7S between early or overt nephropathy and nondiabetic renal disease in diabetic patients with micro- or macroalbuminuria. Nephron 1996; 73: 601-605.
30. Ishimura E, Nishizawa Y, Shoji S, Mori H. Serum type III, IV collagen and TIMP in patients with type II diabetes mellitus. Life Sci 1996; 58: 1331-1337.
31. Hayashi Y, Makino H, Ota Z. Serum and urinary concentrations of type IV collagen and laminin as a maker of microangiopathy in diabetes. Diabetic Med 1992; 9: 366-370.
32. Okazaki R, Matsuoka K, Atsumi Y, Maruyama K, Matsuki H, Okazaki I. Serum concentrations of basement membrane proteins in NIDDM as a prognostic marker for nephropathy. Diabetes Res Clin Pract 1995; 27: 34-49.
33. Brocks DG, Neubauer HP, Strecker H. Type IV collagen antigens in serum of diabetic rats: a maker for basement membrane collagen biosynthesis. Diabetologia 1985; 28: 928-932.
34. Martin J, Davies M, Thomas G, Lovett DH. Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor. Kidney Int 1989; 36: 790-801.
35. Davies M, Martin J, Thomas GJ, Lovett DH. Proteinases and glomerular matrix turnover. Kidney Int 1992; 41: 671-678.
36. Keeley FW, Elmoselhi A, Leenen FHHH. Effects of antihypertensive drug classes on regression of connective tissue components of hypertension. J Cardiovasc Pharmacol 1991; 17 (suppl 2): S64-S69.
37. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, et al. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther 1995; 273: 509-515.
38. Hasslacher C, Brocks D, Mann J, Mall G, Waldherr R. Influence of hypertension on serum concentration of type IV collagen antigens in streptozotocin-diabetic and non-diabetic rats. Diabetologia 1987; 30: 344-347.
39. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, et al. Contribution of renal angiotensin II type I receptor to gene expression in hypertension-induced renal injury. Kidney Int 1994; 46: 1346-1358.